CFDE Workbench
Information PortalData PortalKnowledge Portal
Search
Graph
Enrichment
Cross
Assistant
Data Matrix
Use Cases
Tools & Workflows
Submit
Documentation
CFDE Workbench

(S)-2-(4-(1-(1-(Quinolin-6-yl)ethyl)-1H-[1,2,3]triazolo[4,5-b]-pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol bioactivity cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B  (Knowledge Graph Assertion)

Target:

cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B

Protein (Entity type)
Source:

(S)-2-(4-(1-(1-(Quinolin-6-yl)ethyl)-1H-[1,2,3]triazolo[4,5-b]-pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol

Compound (Entity type)
Relation:

bioactivity

Knowledge Graph Relation (Entity type)
Dcc Asset:

IDG.zip

Processed File (Entity type)
Dcc:

IDG

DCC (Entity type)
Sab:IDGP
Evidence Class:"IC50"
Results found
CFDE Workbench
Report a bug
Consortium
About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
Community
Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
Resources
Data & MetadataToolsChatbotUse CasesPublications
@CFDE Workbench 2025
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
Consortium
About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
Community
Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
Resources
Data & MetadataToolsChatbotUse CasesPublications
CFDE Workbench
Report a bug
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
@CFDE Workbench 2025
This repository is under review for potential modification in compliance with Administration directives.